Skip to main content
. Author manuscript; available in PMC: 2021 Apr 1.
Published in final edited form as: Transfusion. 2020 Mar 12;60(4):747–758. doi: 10.1111/trf.15743

TABLE 3.

Genotype frequencies for the longitudinal and cross-sectional cohorts

FT females n = 200 Frequent FT females n = 114 HI females n = 92 FT males n = 200 Deferred males n = 33 HI males n = 136

Longitudinal cohort HFE C282Y Wild type 180 (90%) 185 (93%) 103 (90%) 27 (82%) 80 (87%) 124 (91%)
Heterozygous 20 (10%) 14 (7%) 11 (10%) 6 (18%) 12 (13%) 12 (9%)
Homozygous 0 (0%) 1 (1%) 0 (0%) 0 (0%) 0 (0%) 0 (0%)
HFE H63D Wild type 142 (71%) 141 (71%) 81 (71%) 25 (76%) 67 (73%) 104 (76%)
Heterozygous 53 (27%) 58 (29%) 32 (28%) 8 (24%) 23 (25%) 31 (23%)
Homozygous 5 (3%) 1 (1%) 1 (1%) 0 (0%) 2 (2%) 1 (1%)
TMPRSS6 A736V Wild type 81 (41%) 33 (29%) 27 (29%) 79 (40%) 9 (27%) 40 (29%)
Heterozygous 86 (43%) 62 (54%) 49 (53%) 82 (41%) 14 (42%) 61 (45%)
Homozygous 33 (17%) 19 (17%) 16 (17%) 39 (20%) 10 (30%) 35 (26%)

FT females n = 2055 Frequent FT females n = 762 HI females n = 788 FT males n = 1713 Deferred males n = 180 HI males n = 1575

Cross-sectional cohort HFE C282Y Wild type 1923 (87.5%) 687 (85.1%) 693 (84.7%) 1600 (88.9%) 162 (88.5%) 1411 (85.4%)
Heterozygous 118 (5.4%) 73 (9%) 91 (11.1%) 91 (5.1%) 18 (9.8%) 156 (9.4%)
Homozygous 14 (0.6%) 2 (0.2%) 4 (0.5%) 22 (1.2%) 0 (0%) 8 (0.5%)
HFE H63D Wild type 1645 (74.8%) 571 (70.8%) 587 (71.8%) 1366 (75.9%) 131 (71.6%) 1146 (69.4%)
Heterozygous 383 (17.4%) 175 (21.7%) 177 (21.6%) 319 (17.7%) 44 (24%) 396 (24%)
Homozygous 27 (1.2%) 16 (2%) 24 (2.9%) 28 (1.6%) 5 (2.7%) 33 (2%)
TMPRSS6 A736V Wild type 759 (34.5%) 289 (35.8%) 272 (33.3%) 621 (34.5%) 60 (32.8%) 553 (33.5%)
Heterozygous 923 (42%) 347 (43%) 397 (48.5%) 778 (43.2%) 83 (45.4%) 748 (45.3%)
Homozygous 373 (17%) 126 (15.6%) 119 (14.5%) 314 (17.4%) 37 (20.2%) 274 (16.6%)